Transaction Date | Recipient | Shares | Type | Price | Value |
---|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Rasna Therapeutics, Inc. develops small molecule drug candidates that focus on treating acute myeloid leukemia. The company was founded in 2013 and is headquartered in New York, NY.
8th March 2021
7th March 2021